PUBLISHER: TechNavio | PRODUCT CODE: 1067581
PUBLISHER: TechNavio | PRODUCT CODE: 1067581
Technavio has been monitoring the drugs of abuse testing market and it is poised to grow by $ 1.24 bn during 2022-2026 progressing at a CAGR of 5.25% during the forecast period. Our report on the drugs of abuse testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increased strategic developments, long-term side-effects of drug abuse, and stringent regulatory control.
The drugs of abuse testing market analysis include Product and Geography segments.
Technavio's drugs of abuse testing market is segmented as below:
By Product
By Geographical Landscape
This study identifies the growing adoption of information management solutions as one of the prime reasons driving the drugs of abuse testing market growth during the next few years. Also, growth of luxury cannabis products and growing adoption of automated diagnostic devices in healthcare will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on drugs of abuse testing market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drugs of abuse testing market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., CareHealth America Corp., Clinical Reference Laboratory Inc., Cordant Health Solutions, Danaher Corp., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Omega Laboratories Inc., Ortho-Clinical Diagnostics Inc., Precision Diagnostics, Psychemedics, Quest Diagnostics Inc., Randox Laboratories Ltd., Shimadzu Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Merck KGaA, and SureHire Inc. Also, the drugs of abuse testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.